Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
2001 1
2002 2
2004 3
2005 4
2006 5
2007 8
2008 9
2009 14
2010 17
2011 11
2012 18
2013 22
2014 15
2015 29
2016 25
2017 15
2018 11
2019 20
2020 24
2021 15
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Results by year
Filters applied: . Clear all
Page 1
Intravitreal aflibercept for diabetic macular edema.
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM. Korobelnik JF, et al. Among authors: do dv. Ophthalmology. 2014 Nov;121(11):2247-54. doi: 10.1016/j.ophtha.2014.05.006. Epub 2014 Jul 8. Ophthalmology. 2014. PMID: 25012934 Clinical Trial.
Aflibercept for neovascular age-related macular degeneration.
Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD. Sarwar S, et al. Among authors: do dv. Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2. Cochrane Database Syst Rev. 2016. PMID: 26857947 Free PMC article. Review.
Reply.
Do DV, Rhoades W, Nguyen QD. Do DV, et al. Retina. 2020 Apr;40(4):e13-e14. doi: 10.1097/IAE.0000000000002711. Retina. 2020. PMID: 31876890 No abstract available.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG. Heier JS, et al. Among authors: do dv. Ophthalmology. 2016 Nov;123(11):2376-2385. doi: 10.1016/j.ophtha.2016.07.032. Epub 2016 Sep 17. Ophthalmology. 2016. PMID: 27651226 Clinical Trial.
Drs. Carter and Do reply.
Carter KL, Do DV. Carter KL, et al. Among authors: do dv. J Rheumatol. 2021 Jan 1;48(1):151. doi: 10.3899/jrheum.200913. Epub 2020 Dec 1. J Rheumatol. 2021. PMID: 33262299 No abstract available.
Reply.
Campochiaro PA, Hafiz G, Mir TA, Scott AW, Solomon S, Zimmer-Galler I, Sodhi A, Duh E, Ying HS, Wenick AS, Shah SM, Do DV, Nguyen QD, Kherani S, Sophie R. Campochiaro PA, et al. Among authors: do dv. Ophthalmology. 2016 May;123(5):e33-4. doi: 10.1016/j.ophtha.2015.11.024. Ophthalmology. 2016. PMID: 27107360 No abstract available.
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF. Brown DM, et al. Among authors: do dv. Ophthalmology. 2015 Oct;122(10):2044-52. doi: 10.1016/j.ophtha.2015.06.017. Epub 2015 Jul 18. Ophthalmology. 2015. PMID: 26198808 Clinical Trial.
Hydroxychloroquine-induced Retinal Toxicity.
Carter KL, Do DV. Carter KL, et al. Among authors: do dv. J Rheumatol. 2020 Apr;47(4):632. doi: 10.3899/jrheum.190538. J Rheumatol. 2020. PMID: 32238544 No abstract available.
250 results